Pharmacists to claim due compensation for Zyprexa business loss.

Published: 2003-12-04 06:56:00

Updated: 2003-12-04 06:56:00

The government reduced the NHI prices of Zyprexa (Olanzapine: anti-psychotic drug) by 14 to 39.9% as of Dec. 1 after its prescription being reclassified from a drug of the 2nd choice to of the first choice, which eventually brought out a business loss to the pharmacies in the market. However, E. ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK